Biochemistry and molecular biology

Follicular lymphoma is currently viewed as a single disease entity – but will recent pathologic findings redefine our perspective?

Voted Number One on The Pathologist Power List, Manuel Sobrinho-Simões, talks profession, politics, education, innovation, and the ups and the downs of a career that has inspired generations of pathologists.

It’s often difficult to target pancreatic cancer cells while sparing healthy tissue – but a new therapy concept not only makes this possible, but also enhances the potential effectiveness of adjuvant treatments

When genetics yielded unsatisfactory answers about pancreatic cancer’s persistent survival, researchers looked beyond the genome – and found telling epigenetic changes

Screening for pancreatic cysts can help with early detection and treatment – but how can we tell which lesions are benign and which may progress to cancer?

Pancreatic cancer is often treated as a homogeneous disease, but new research reveals distinct subtypes of tumor and stromal gene expression

Pancreatic cancer is a challenge to stage because there’s no good molecular imaging method – but three new antibody conjugates may change that

Circulating tumor cells may hold information crucial for better pancreatic cancer diagnosis and treatment – but locating them needs special tactics

RNA in situ hybridization offers a new way to overcome the challenges of advancing RNA cancer biomarkers to the clinic

We Sit Down With Michael Wells, Past President of the European Society of Pathology.